Linc
Linc AB is a Swedish investment company focused on investing in life science and biotechnology companies in the Nordic region. The company operates as an active owner, providing financial capital, strategic guidance, and operational support to pharmaceutical, medical technology, and diagnostic enterprises in its portfolio. Its investment strategy targets companies with high growth potential and innovative clinical pipelines. Revenue and financial returns are derived from capital appreciation, dividend distributions, and strategic divestments of portfolio holdings. Linc holds an established position in Swedish life science venture capital and investment. The company is headquartered in Stockholm, Sweden, and its shares trade on Nasdaq Stockholm.
7 of the funds FundTelligence covers report a position in Linc.
- Legal name
- Linc AB
- Sector
- Financials
- Country
- Sweden
- Funds holding it
- 7
Funds holding Linc
- Kavaljer Investmentbolagsfond — Kavaljer · 4.1 % (partially disclosed portfolio, October 2026)
- Swedbank Robur Småbolagsfond Norden — Swedbank · 1.52 % (full portfolio disclosed, October 2026)
- Nordea Nordic Small Cap — Nordea Funds · 0.53 % (full portfolio disclosed, July 2026)
- Nordea Nordic Small Cap Fund — Nordea Funds · 0.53 % (full portfolio disclosed, July 2026)
- Storebrand Sverige Småbolag Plus — Storebrand · 0.14 % (full portfolio disclosed, October 2026)
- Storebrand Sverige Plus — Storebrand · 0.04 % (full portfolio disclosed, October 2026)
- Handelsbanken Norden Index Criteria — Handelsbanken · 0.01 % (full portfolio disclosed, October 2026)